Warner Chilcott To Present At The 2012 UBS Global Life Sciences Conference

DUBLIN, Ireland, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief Executive Officer, and Paul Herendeen, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2012 UBS Global Life Sciences Conference on Wednesday, September 19 th at 10:00 a.m. EDT.

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm , with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm .

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the pharmaceutical markets, primarily in North America. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G
CONTACT: Emily Hill         Investor Relations         973-907-7084         Emily.Hill@wcrx.com

Warner Chilcott Logo

If you liked this article you might like

Warner Chilcott PLC (WCRX): Today's Featured Health Care Laggard

Warner Chilcott PLC (WCRX): Today's Featured Health Care Laggard

Warner Chilcott PLC (WCRX): Today's Featured Health Care Laggard

Warner Chilcott PLC (WCRX): Today's Featured Health Care Laggard

Warner Chilcott PLC (WCRX): Today's Featured Health Care Winner

Warner Chilcott PLC (WCRX): Today's Featured Health Care Winner

Warner Chilcott PLC (WCRX): Today's Featured Health Care Winner

Warner Chilcott PLC (WCRX): Today's Featured Health Care Winner

These Look Primed for Breakout

These Look Primed for Breakout